POM Pomdoctor Limited
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.…
Industry Peers
Pharmaceutical RetailersKey Statistics
About Pomdoctor (NASDAQ: POM)
›
Pomdoctor (NASDAQ: POM) is listed on Nasdaq, where its shares trade in USD. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 165 employees.
The shares were at 1.610 USD on 19 November 2026, down 97.9% over 52 weeks. Its 52-week range is 0.4330 USD to 102.42 USD: the price is 98.4% below the high and 271.8% above the low.
Its market capitalisation is 57.91M USD.
Pomdoctor reports return on equity of 46.8%, an operating margin of -82.3% and revenue up 6.0% year over year.
Its debt exceeds its cash by 437.52M CNY. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.